Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-08-13Single-center, Open-label, Non-randomized, Two-period Sequential Treatment Study to Assess the Effect of Neomycin on the Pharmacokinetics of Regorafenib in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2015-07-27A Phase I, Open-Label, Multicenter, Dose-Escalation Study of the Safety and Pharmacokinetics of a Recombinant Humanized Antibody to Her2 (rhuMAb 2C4) Administered Every 3 Weeks to Subjects With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2015-07-08Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer
-
CLINICAL_TRIALS study record update · 2015-05-22Yoga Cancer Rehabilitation Study
-
CLINICAL_TRIALS study record update · 2015-05-21Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-05-20A Phase I and Pharmacokinetic Study of NM-3 Administered Orally Once or Twice Daily on Five Consecutive Days and Repeated Weekly for Six Weeks Every Eight Weeks in Patients With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2015-05-06Phase I Trial of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine
-
CLINICAL_TRIALS study record update · 2015-05-04Computerized Assessment for Patients With Cancer
-
CLINICAL_TRIALS study record update · 2015-04-17Phase Ib Trial of the Combination of PI3K Inhibitor BAY 80-6946 and Allosteric-MEK Inhibitor BAY 86-9766 in Subjects With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2015-04-08Palliation of Biliary Neoplasms With the Cook Evolution® Biliary Stent System
-
CLINICAL_TRIALS study record update · 2015-04-08A Phase I, Open-Label, Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Aneustat™ (OMN54) Administered on a Daily Oral Regimen in Patients With Advanced Cancer and Lymphomas
-
CLINICAL_TRIALS study record update · 2015-04-07Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients
-
CLINICAL_TRIALS study record update · 2015-04-01A Multi-Centre, Randomised, Open-Label Active-Controlled Study Comparing Safety and Efficacy of Synergo Radiofrequency (RF)-Induced Hyperthermia-Chemotherapy With Mitomycin C (RITE) Versus Bacillus Calmette-Guérin (BCG) as First-Line Treatment of Non-Muscle Invasive Papillary Bladder Cancer (NMIBC)
-
CLINICAL_TRIALS study record update · 2015-03-25A Phase I Study of Anti-CD3 x Cetuximab-Armed Activated T Cells, Low Dose IL-2, and GM-CSF for EGFR-Positive, Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-03-20Multi-site Evaluation of a Video Game for Adolescents and Young Adults With Cancer
-
CLINICAL_TRIALS study record update · 2015-03-06National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients
-
CLINICAL_TRIALS study record update · 2015-02-18Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-02-16ClinicalTrials.gov study NCT00040534
-
CLINICAL_TRIALS study record update · 2015-02-10A Phase I Study of Ridaforolimus (MK8669) and MK0646 in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2015-02-09Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.
-
CLINICAL_TRIALS study record update · 2015-01-28A Phase I Open-label Dose Escalation Study of Once-daily Oral Treatment With BIBF 2992 for 21 Days in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-01-26A Phase 1, Multicenter, Open-label, Dose-escalation, Safety, Pharmacokinetic, And Pharmacodynamic Trial Of Cvx-060, A Selective Angiopoietin-2 (Ang-2) Binding, Anti-angiogenic Covx-body, In Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-01-22An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-free Survival in Patients With Progressive Advanced/Metastatic Well-differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract
-
CLINICAL_TRIALS study record update · 2015-01-21An Open Label Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-01-16A Phase 1b, Multi-Center, Open Label, Uncontrolled, Serial Cohort, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Daily Oral Doses of ZSTK474 in Subjects With Advanced Solid Malignancies